In summary, these findings suggest that while SLC50A1 overexpression may enhance DNA damage repair in DOX-treated HCC cells via the glycolytic pathway, 2-DG can intensify cellular DNA damage. Here, SLC50A1 is linked to hepatocellular carcinoma.